Avalo Therapeutics Announces Pricing of $375 Million Public Offering
Avalo Therapeutics priced a $375M public offering, selling 19.73M shares of common stock at $17.75 per share and 1.4M pre-funded warrants. Underwriters have a 30-day option to purchase an additional 3.17M shares.
Key figures
- Deal Value Usd
- 375000000
- Offering Price
- 17.75
- Shares Offered
- 19730000
- Warrant price
- 17.749
- Pre funded warrants
- 1400000
- Underwriter option shares
- 3169500
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.